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MITOCHONDRIAL DNA REGULATES TNF-ALPHA MRNA STABILITY 
 
STEPHANIE BOND 
 
ABSTRACT 
 
Sepsis is defined as potentially fatal systemic inflammation, caused by an 
infection. It is the leading cause of ICU mortality and the 10th leading cause of death in 
the United States. Several models exist to mimic this disorder, and have demonstrated 
differential mortality rates between the models as well as the individual animals. Previous 
studies have shown that elevated levels of plasma mitochondrial DNA (mtDNA) 
correlated with mortality in septic patients, and cell-free mitochondrial DNA can elicit 
toll-like receptor mediated immune responses similar to LPS-mediated septicemia.  
However, the role of mtDNA in the pathophysiology sepsis is still unknown.  
 The focus of this study was to create sepsis in a mouse model using the murine Cecal 
Ligation and Puncture (CLP) model, and measure plasma mtDNA levels. After CLP was 
performed on experimental mice, blood plasma was collected 24 hours later. Elevated 
amounts of circulating mtDNA were detectable in the plasma using real time PCR and 
cytochrome B2 as a marker of mitochondria. These data were correlated with plasma IL-
6 levels, which were used to predict mortality within 5 days of CLP to stratify mice into 
two populations of those predicted to live or die following the procedure. 
We also aimed to investigate the effect of mtDNA and mitochondrial debris on 
naïve mouse macrophages in an in vitro study of the regulation of inflammatory 
cytokines interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and interleukin-1 
beta (IL-1β). In order to observe the effects of mtDNA on murine macrophages, 
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mitochondria was purified from mouse liver and used to stimulate these cells alongside 
positive control, LPS. Stimulation with mtDNA and mitochondrial debris resulted in 
increased levels of TNF-α mRNA in lysed cells as well as their surrounding media as 
compared to control cells, as well as increased transcript half life as measured over four 
hours post stimulation with transcription inhibitor actinomycin D. The increases in 
mRNA half-life elicited by mtDNA were comparable to those observed after LPS 
addition. Stimulation also caused increased binding of TNF-α mRNA to the RNA binding 
protein, AUF1, as measured by immunoprecipitation of RNA-protein complexes and 
assayed for TNF-α binding by PCR. These results demonstrate that mitochondrial 
damage-associated molecular patterns regulate TNF-α mRNA expression at the post-
transcriptional level through AUF1, an mRNA destabilizing factor. This is a novel 
mechanism that likely contributes to sepsis pathophysiology, and demonstrates the 
involvement of the mitochondrial fission and fusion balance and its regulation in the 
sepsis innate immune response. 
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INTRODUCTION 
 
Sepsis Overview 
Sepsis is a common, expensive, and highly fatal public health concern, associated with 
significant health care cost. Between 2003 and 2007, a 71% increase in cases of severe 
sepsis was identified alongside an increase in hospital costs to 24.3 billion dollars for all 
patients in 2007 (Lagu et al., 2012). The condition is considered the 10th leading cause of 
death overall in the United States, with its incidence projected to increase to more than 
1,110,000 cases annually by 2020 (Martin et al., 2003; Namas et al., 2012; Angus et al., 
2001). Fortunately however, following advances in critical care medicine over the past 
two decades, the estimated mortality rate due to sepsis has decreased to less than 30% 
(Stevenson et al., 2014). Septic shock is typically initiated by a bacterial infection, 
causing the uncontrolled expression of proinflammatory cytokines and a systemic 
inflammatory response. Broadly, septic patients are often characterized as having 
increased levels of tumor necrosis factor alpha (TNF-α), interleukin-1beta (IL-1β), IL-6, 
and IL-8: cytokines that are predominantly produced by monocytes and macrophages. 
Overproduction of these mediators results in host tissue destruction, multiple organ 
dysfunction and the associated morbidity of septic shock (Hotchkiss et al., 2003; 
Fitzsimmons, 1994). Current treatments focus on antibiotic therapy, fluid resuscitation, 
and supportive care of failing organ systems (Dellinger et al., 2013). Large-scale clinical 
trials have also attempted to dampen the inflammatory response through blocking the 
actions of inflammatory mediators such as TNF-α and interleukin-6 (IL-6) (Kox et al., 
2000; Zanotti et al., 2002). However, these efforts to improve sepsis survival have failed 
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to lower the mortality rate of afflicted patients (Remick, 2003). Drotrecogin alfa, a 
recombinant activated protein C and the only approved drug specifically indicated as a 
treatment for severe sepsis, was also removed from the market after significant 
improvements in survival during an earlier trial were unable to be confirmed by 
subsequent trials (Angus, 2011).  
 
Experimental models have imitated septic shock using lipopolysaccharide (LPS), a 
component in the outer membrane of Gram-negative bacteria (Park and Lee, 2013). 
Excessive response by the innate immune system to microbial products such as LPS was 
hypothesized to contribute to the clinical symptoms of septic shock after activating host 
intracellular signaling pathways (Barochia et al., 2011). These pathways include toll-like 
receptor 4 (TLR4), a complex present on host-cell surfaces that upon binding of LPS, 
induces intracellular signaling and the eventual release of pro-inflammatory cytokines, 
chemokines, and other molecules that are associated with the excessive inflammatory 
response related to sepsis. However, clinical studies with eritoran, a TLR4 antagonist 
developed to inhibit endotoxin challenge induced cytokine production, failed to 
demonstrate improved survival in patients with severe sepsis (Barochia et al., 2012; Tse, 
2013). These failed studies demonstrate that targeting a different mechanism behind the 
inflammatory over-response of sepsis is required to develop novel agents for effective 
treatment. 
Our current understanding of sepsis also welcomes discussion of the various animal 
models used to study the condition and allow development of new therapies. Besides the 
  3 
above-mentioned model of sepsis initiated through LPS challenge, one of the most 
widely used clinical models is the cecal ligation and puncture (CLP) technique (Toscano 
et al., 2011). Using this model, perforation of the cecum and release of cecal contents 
into the peritoneal cavity elicits a similarly aggressive immune response to human sepsis 
or polymicrobial infection. This model reproduces clinical emergencies such as a 
perforated appendix or penetrating trauma, and mimics several aspects of human 
pathology such as hemodynamic alterations and changes in body temperature. The 
cytokine profiles reported from mouse models of sepsis are also similar to those seen in 
the human analog, involving the upregulation of pro-inflammatory TNF-α, IL-1β, and IL-
6 cytokine expression (Buras et al., 2005; Toscano et al., 2011). It has also been 
demonstrated that IL-6 cytokine levels measured 6 hours after CLP could accurately 
predict future mortality (Remick et al., 2002). This allows for stratification of animals 
into populations that will either live or die following CLP. These two groups can then be 
analyzed for differences that might act as potential therapeutic targets. The effort to 
develop reproducible models that allow for potential sepsis therapies has been burdened 
by the complex pathophysiology of the condition; however, CLP offers a model whose 
severity can be graded, but is relatively easy and inexpensive to use when developing 
novel therapeutics. This model also includes supportive care in the form of antibiotics 
and fluid resuscitation, similar to current clinical interventions that improve survival. 
 
A Role for Mitochondria  
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Mitochondria, similar in characteristics to the prokaryote, are carriers of their own 
mitochondrial DNA (mtDNA). With its lack of histones and utilization of CpG motifs, 
mtDNA has inflammatory abilities similar to its bacterial cousin (Collins et al., 2004). 
There is evidence that further mimicking bacterial DNA, cell-free mtDNA act as a 
damage-associated molecular pattern (DAMP), driving the processes that produce pro-
inflammatory cytokines (Simmons et al., 2013). Injury-derived mitochondrial DAMPs 
are recognized by the innate immune system through pattern recognition receptors 
(PRRs) that also sense bacterial products, activating the same TLR pathways that elicit 
inflammation and non-specific organ attack. Several roles for mitochondrial dysfunction 
have also been illuminated in various disease states: Collins et al. (2004) reported that 
purified mtDNA injected intra-articularly causes arthritis, and Zhang et al. (2010) found 
that injected mitochondrial DAMPs resulted in inflammatory lung injury in rats. During 
sepsis, there is dysregulation of mitochondria number, structure, and function, reflecting 
the process of mitochondrial shutdown during a period of decreased energy availability 
and associated metabolic pathways (Singer, 2007). Likely as a part of these mitochondrial 
changes, circulating, cell-free mtDNA increases in concentration (Zhang et al,,2010), 
while cellular mtDNA levels decrease (Pyle et al., 2010). Circulating mtDNA that 
escapes autophagy activates TLR-9 receptors to enact an inflammatory response, 
including the activation of host neutrophils by mtDNA-associated DAMPs via p38 map 
kinase (Zhang et al., 2010; Nakahira et al., 2011). This neutrophil activation mediates the 
oxidant organ injury demonstrated in studies by Zhang et al. (2010) (Simmons et al., 
2013). 
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Due to these inflammatory properties, serum mtDNA has been assessed as a potential 
biomarker for sepsis mortality in ICU patients. Indeed, in patients presenting with sepsis, 
increased circulating cell-free mtDNA levels were associated with increased patient 
mortality (Nakahira et al., 2013; Cao et al., 2013). These findings suggest that mtDNA 
could contribute to the development of sepsis through its induction of the innate immune 
system responses including pro-inflammatory cytokine expression. Exploration of the 
relation of mtDNA to the pathogenesis of sepsis could therefore provide groundwork for 
future treatments. 
 
Cytokine mRNA Stability  
The central tenant of sepsis research currently focuses on suppression of the host 
response of excessive cytokine production to improve patient outcome (Angus, 2011). 
However, recent studies on pro-inflammatory cytokine suppression therapies for sepsis 
have proven them largely ineffective. One such study by Newham et al. (2014) reported 
that a proposed anti-TNF-α agent, AZD9773, was not associated with survival benefit in 
a mouse CLP sepsis model. Thus, though the expression of TNF-α is related to sepsis 
severity, its suppression alone does not increase 5-day mortality. 
 
Cytokine levels are regulated at several steps in their production, including the stability of 
their encoding mRNA (Chen and Shyu, 1995). The stability of mRNA that determines its 
turnover, and is linked to its translation, was discovered to be encoded by sequences of 
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the mRNA itself. These elements of stability—or instability—determine an mRNA’s rate 
of degradation in the cytoplasm (Gratacos and Brewer, 2013). Studies of TNF-α 
demonstrate that it promotes its own stability during the inflammatory response by 
activating the p38 mitogen-activated protein kinase (MAPK) pathway, which directly 
stabilizes its unstable mRNA, increasing the amplitude of the inflammatory response 
(Saklatvala et al., 2003). The instability of the mRNA of other pro-inflammatory 
cytokines such as IL-1β, which are also short-lived, is regulated by AU-rich elements 
(ARE) in their 3’ noncoding regions. These ARE promote the cytoplasmic degradation of 
mRNAs through a deadenylation-dependent decay pathway, and it is hypothesized that 
different types of ARE sequences can confer different mRNA decay rates (Lu et al., 
2006; Sarkar et al., 2003). Many unstable mRNAs contain such ARE sequences in their 3’ 
untranslated region, allowing for degradation through the removal of the poly(A) tail and 
subsequent degradation of the body of the mRNA (DeMaria and Brewer,1996). In-vitro 
RNA binding studies demonstrate that protein factors bind AU-rich sequences, and that 
the number of tandemly repeated AUUUA motifs increases alongside binding and 
associated mRNA instability. The characteristics of the context in which these factors are 
present can determine the resulting predicted mRNA stability. Repeated AUUUA 
pentamers are associated with many labile protein mRNAs, including growth factors, 
cytokines, and various transcription factors. This demonstrates that mRNA half-life is 
mediated through high affinity binding sites for decay elements, the key to which 
involves AU-rich sequence motifs (Zubiaga et al., 1995).  
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The Destabilizing Factor AUF1  
Though destabilization of mRNAs through their AREs is still poorly understood, various 
ARE-binding proteins have been demonstrated to regulate rapid mRNA decay in vivo, 
including the ARE- and poly(U)-binding and degradation factor, AUF1 (von Roretz et al., 
2011). AUF1, also known as hnRNP D, was discovered as a factor in the degradation of 
c-myc mRNA in a cell-free mRNA degradation system (Gratacos and Brewer, 2010; 
Zhang et al., 1993). It has been identified as a family of isoforms, derived through four 
alternative splices of a pre-mRNA (Wagner et al., 1998). This quality of the AUF1 
family of isoforms is thought to give the proteins functional versatility. AUF1 has been 
shown to generally have a destabilizing effect on ARE-mRNAs, though it has been found 
to act as both a decay and stabilizing factor for different transcripts. Beyond accelerating 
mRNA decay, AUF1 may act on mRNA for other roles, regulating even transcriptional or 
translational activities (Moore et al., 2014). 
 
AUF1 and its interaction with mRNA have since been studied to determine the effects of 
AUF1 phosphorylation on monocyte-derived mRNA, including cytokine expression 
(Gratacos and Brewer, 2010). It had been demonstrated that AUF1 has a role in various 
biological pathways, as AUF1 knock-out (KO) models demonstrated many physiological 
defects, some caused by the loss of mRNA degradation (Moore et al., 2014). Many of 
their phenotypes involved the dysregulation of cytokines, growth factors, and chemokines, 
physiological factors known to contain the AUUUA pentamer that supports AUF1 
binding. It has been demonstrated through the development of AUF1-null models that 
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AUF1 is essential to the inflammatory process, as endotoxin-challenged mice display the 
signs and symptoms associated with severe endotoxic shock, as well as the 
overproduction of the pro-inflammatory cytokines TNF-α and IL-1β (Moore et al., 2014; 
Lu et al., 2006). This finding suggests that AUF1 may act as an attenuator for the 
inflammatory response, allowing for decay of proinflammatory cytokine mRNAs 
following activation by present endotoxins. The overproduction of these two cytokines 
was also specific, AUF1 did not promote degradation of IL-6 mRNA, a cytokine 
involved in septic shock progression, but differing in its ARE sequence and therefore 
unable to support a strong interaction with AUF1. AUF1 has been also linked to 
inflammation through the development of chronic ectopic dermatitis in AUF1 KO mice 
(Sadri and Schneider, 2009). mRNA stability and associated proteins interact with 
leukocyte recruitment and inflammatory activity, suggesting the interconnection of AUF1 
and other identified targets of potential sepsis treatments. 
Combining the previously discussed CLP model with the AUF1 KO mice will determine 
of the role of mRNA stability in response to sepsis. Observing the progression of sepsis 
within AUF1 transgenic mice, and the role of mtDNA in regulating mRNA stability, 
could provide avenues for novel therapeutic development and determine the appropriate 
time course for possible interventions. 
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METHODS 
 
Animals 
Outbred female ICR7 mice (Harlan-Sprague Dawley, Inc., South Easton, MA) between 
24-30 grams were used for all studies. Mice were received and allowed to acclimate to 
our housing room for at least 96 hours prior to surgery. Mice were given food and water 
ad libitum for the entire duration of the experiment, and were kept in a temperature and 
humidity controlled room with a diurnal cycle of 12 hours light, 12 hours dark. The 
experiments were approved by the Boston University Animal Care and Use Committee. 
 
CLP model of sepsis 
Cecal ligation and puncture (CLP) was performed as described previously (Wichterman 
et al., 1980) with minor modifications (Ebong et al., 1999). Mice were first anesthetized 
in an induction chamber with 5% isofluorane, followed by 3% for maintenance under 
nose cone during surgery. The abdomen was shaved and wiped with alcohol and 
chlorhexidine (Chloraprep). The abdominal skin was opened and an incision was made 
through the linea alba. The cecum was eviscerated and ligated below the ileocecal valve, 
approximately two-thirds of its length from the distal tip with 4-0 silk. The cecum was 
then punctured twice longitudinally with a 16 gauge needle. Enough fecal content was 
squeezed out both puncture sites to ensure patency, then the cecum was returned to its 
original position. The abdominal cavity was then closed with 4-0 silk sutures, and the 
skin closed with wound glue (Nexaband, Veterinary Products Laboratories, Phoenix, AZ). 
Mice were resuscitated with 1 mL of warm saline (37°) with buprenorphine (0.05mg/kg) 
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for pain management, receiving 1 injection every 12hours for the first two days post-CLP. 
Mice also received antibiotic treatment with 25 mg/kg Primaxim in 1 mL 5% dextrose in 
water with lactated Ringer solution 2 hours post-CLP, and then once every 12 hours for 
the first 5 days. 
 
Blood sampling 
Blood sampling was performed at 24 hours following CLP to generate IL-6 Receiver 
Operator Characteristic (ROC) curves and to also allow for assays of plasma mtDNA 
levels. For IL-6 ROC analysis, 20 uL of blood was collected by facial vein puncture and 
diluted 1/10 in PBS containing 3.38 mM 3.38mM EDTA tripotassium salt before being 
immediately placed on ice. In mice sacrificed at 24 hours, blood was collected using 
terminal exsanguination via the retro-orbital venous plexus under anesthesia (87 µg/g 
Ketamine and 13 µg/g Xylazine in normal saline) into 100uL Heparin (1000U/mL). This 
procedure was followed by euthanasia via cervical dislocation. 20uL of blood was also 
collected separately during exsanguination, and diluted 1/10 in HBSS containing 3.38mM 
EDTA tripotassium salt before being immediately placed on ice. All blood samples were 
centrifuged for 5 min at 1000 X g at 4°C, and the plasma was collected and frozen at -
20°C for subsequent analysis of the facial vein bleeds for IL-6 cytokine levels to predict 
animal survival rate, or the whole plasma for DNA purification using a QIAamp DNA 
Blood Mini kit to determine serum mtDNA concentration. 
 
 
  11 
Harvest of peritoneal cells 
Non-CLP mice were used for this terminal procedure. Elicitation and isolation of 
macrophages was completed as previously described, with modification (Zhang et al., 
2008). Mice were challenged with 3 mLs of 3% thioglycollate injected into the 
intraperitoneal cavity using a 27-gauge needle, and were then monitored in standard 
cages in the housing as was performed for mice subjected to CLP. Mice were then 
euthanized using ketamine (87 mg/kg) and cervical dislocation. Macrophages were 
harvested from the peritoneal cavity using standard methods for intraperitoneal lavage 
using 10 mL warm Hanks’ Balanced Salt Solution (HBSS, Mediatech Inc., Herndon, VA) 
containing 0.5 mM EDTA. Lavage samples were centrifuged and the pellet was lysed 
with 1mL 0.2% hypotonic saline for 40 seconds before restoration to isotonicity with 
1.6% hypertonic saline. Cells were washed once with HBSS containing 1% fetal bovine 
serum (FBS), and were resuspended in 2mL of cell culture media before being counted. 
Total cell counts were performed with a Beckman-Coulter particle counter model ZF 
(Coulter electronics Inc., Hialeah, Fl). 
 
ELISA 
An aliquot of 1/10 diluted plasma collected at 24 hours was diluted 1/5 in dilution buffer 
for a final dilution of 1/50, and then analyzed for IL-6 concentrations by ELISA as 
previously described (Nemzek et al., 2001). The plasma IL-6 concentrations of mice 
followed for survival were used to generate a Receiver Operator Characteristic curve to 
generate IL-6 values predictive of mortality. This curve was used to posthumously 
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stratify mice sacrificed at 24 hours into populations projected to either be alive or dead 
five days post CLP, as previously described by Remick et al., 2002. 
Levels of TNF-α secreted by primary macrophages were also determined through ELISA, 
using an equal amount of culture supernatant at indicated time-points following 
stimulation by LPS, mtDNA or mitochondrial debris. 
 
Real-time PCR protocols 
DNA was prepared from 200 uL plasma using QIAamp DNA Blood Mini Kit from 
Qiagen, according to the manufacturer’s protocol. Purified DNA was used for each real-
time PCR reaction using SYBR Green Master Mix (Applied Biosystems, Foster City, 
Calif) by StepOne Plus RT-PCR Systems (Applied Biosystems, Foster City, Calif). 
Primers for the mitochondrial marker Cyt B2 were synthesized by Invitrogen. A standard 
curve was created to quantify mtDNA concentration in the plasma samples using mtDNA 
purified from mouse liver and Cyt B as the target. All data analyses were done according 
to the manufacturer’s protocol. 
 
Preparation of mitochondrial debris and mtDNA 
Mitochondria were isolated from mouse liver acquired from female ICR7 mice (24-30 g; 
Harlan-Sprague Dawley, Inc., South Easton, MA). Tissue samples were used to isolate 
liver mitochondria according to the protocol for Dounce homogenization of soft tissue as 
previously described (Frezza et al., 2007). During douncing, homogenizers were cooled 
to 4°C, and 10 mL of homogenization buffer was used to prepare one whole liver (0.32 
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M sucrose; 1 mM EDTA; 10mM Tris-HCL, pH 7.8). Mitochondrial pellets were isolated 
and stored at -80°C to provide mitochondrial debris, as well as mtDNA for later isolation. 
To prepare mitochondrial debris, a protease inhibitor cocktail (1:100) in 1 mL of cell 
culture media was added to the mitochondrial pellet, which was then sonicated on ice 
using a Misonix ultrasonic liquid sonicator (Misonix Inc., Farmingdale, New York) at 
100% amplitude, 10 times for 30 s each with a 30 s interval as previously described 
(Zhang et al., 2010).  
Mitochondrial DNA was isolated from mouse liver pellets through suspension in a lysis 
buffer containing 10 mM Tris-HCl (pH 8.0), 150 mM NaCL, 20 mM EDTA, 1% SDS 
and 0.2 mg/mL Proteinase K, followed by a phenol-chloroform extraction and ethanol 
precipitation. Ethanol precipitated mtDNA was further purified using an RNeasy spin 
column kit (Qiagen, Valencia, Calif). Purity of the mtDNA was assessed using 
quantitative real-time PCR to probe for the presence of mitochondrial gene cytochrome 
B2 (Cyt B2), and nuclear specific HPRT to assess for contamination. 
 
Cytokine expression kinetics 
Cytokine expression by primary macrophages over time was quantified using 
comparative real time PCR. Peritoneal macrophages were seeded into a 24-well plate 
(3.5x105 cells/well) and incubated at 37°C in an atmosphere of 5% CO2 overnight to 
allow for adherence. Macrophages were stimulated with either cell culture media, 100 
ng/mL LPS (Sigma), or mitochondrial debris before total RNA isolation after 0, 30, 60, 
120 minutes; or 0, 1, 2, 4 and 18 hours, post-stimulation. Culture supernatant was saved 
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for later cytokine ELISA assays, and cells were removed in 350 uL Qiazol (Qiagen) for 
RNA extraction. TNF-α and IL-1β mRNA levels were quantified using quantitative PCR 
(StepOne Plus, Applied Biosystems), normalized to GAPDH, on cDNA processed using 
an iScript cDNA synthesis kit (Bio-Rad). PCR reactions were performed with gene-
specific primers made by Invitrogen.  
 
Determination of mRNA half-life 
Decay studies were performed on previously described isolated peritoneal macrophages 
also seeded into a 24-well plate. Macrophages were stimulated with culture media, LPS, 
or mitochondrial debris for 4 hours. After stimulation, actinomycin D (10 ug/mL) was 
added to block transcription, and total RNA was isolated 0, 30, 60, and 120 minutes post-
actinomycin D treatment. Samples were harvested and RNA extraction was completed 
using Qiazol (Qiagen), and TNF-α mRNA levels were determined using quantitative real-
time RT-PCR, normalized to GAPDH. Half-lives of mRNAs were calculated by plotting 
normalized TNF-α mRNA versus time, and linear regression analysis was used to 
determine the slope of each decay curve. 
 
Immunoblot analysis 
Cell lysates were prepared through seeding isolated peritoneal macrophages into three 
replicative 10-centimeter diameter plates (5x105 cells/well), and stimulated with culture 
media, LPS, and mitochondrial debris as described above. After four hours of stimulation, 
cells were scraped in PBS and pelleted in a microcentrifuge tube by a five-minute 
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centrifugation at 2500 rpm. Pellets were resuspended in 1 mL of RIP buffer (20 mM Tris 
HCl, pH 8.0; 137 mM NaCl; 1% glycerol; 0.1% NP-40; 2 mM EDTA) and incubated on 
ice, vortexing on low every 10 minutes for 20 minutes, to disrupt nuclei. Lysates were 
centrifuged at 13,000 rpm for 20 minutes at 4°C and supernatants were transferred to a 
new microcentrifuge tube. Protein concentration was quantified by Lowry assay (Bio-
Rad). Equal amounts of cell lysates were resolved by SDS-polyacrylamide gel 
electrophoresis (PAGE) and transferred to the membrane, and immunoblotting was 
performed using a primary antibody against AUF1 (Millipor). Immunoblots were 
developed using infrared fluorescence (Li-Cor Biosciences) and imaged on the Odyssey 
imaging system (Li-Cor Biosciences). 
 
Immunoprecipitation qRT-PCR 
Cell lysates were immunoprecipitated (IP) with AUF1 or IgG antibodies using an A/G 
bead slurry (Pierce Biotechnology). Immunoprecipitated TNF-α mRNA was harvested 
using Qiazol and analyzed using quantitative real-time RT-PCR to assess TNF-α mRNA 
levels normalized to GAPDH. 
 
Statistical Analysis 
Statistics were performed using Prism 5 software (Graphpad Software, San Diego, CA). 
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RESULTS 
 
To study the role of mitochondrial dysfunction in septicemia, a CLP model was used to 
determine if there was a difference in plasma mtDNA levels in mice predicted to live or 
die. The CLP model used produces a 50% mortality rate on average within the first five 
days of sepsis (Acute phase) (Figure 1a). Blood sampling and monitoring of plasma IL-6 
by ELISA at 24 hours post CLP demonstrated that non-survivors of sepsis have elevated 
IL-6 levels, as plasma IL-6 has been established as a biomarker of sepsis mortality in 
mice undergoing CLP (Figure 1b; Remick et al., 2002). Receiver Operator Characteristic 
curves of the plasma IL-6 of mice monitored for survival were used to generate 
discrimination values to stratify mice into populations predicted to live or die and to 
optimize sensitivity and specificity of the assay. A Receiver Operator Characteristic 
(ROC) curve of area 0.5 + 0.1259 under the curve (AUC) indicated that plasma IL-6 
levels < 0.091 ng/mL provided 100% sensitivity for the mice which were alive at day 5 
post CLP, and levels > 4.69 ng/mL provided 82% specificity. This method, described 
previously by Remick et al., 2002, allowed for posthumous stratification of mice 
sacrificed at 24 hours post-CLP for their total blood volume, using an IL-6 cut-off value 
determined using the ROC curve to be 3.51 ng/mL (Moitra et al., 2012). 
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Two groups of mice predicted to live or die following CLP were compared in terms of 
plasma mtDNA levels, where mice predicted to die had greater plasma mtDNA content 
than those predicted to live (Figure 2). The results of this study did not prove to be 
significant, but provide directional evidence of congruency with previous studies of 
human ICU patients that suggests circulating mtDNA is somehow involved in the 
pathophysiology of severe sepsis, and is a biomarker for mortality (Nakahira et al., 2013). 
As inflammatory cytokines demonstrate a peak in expression following the initiation of 
sepsis, such as the peak of IL-6 at 6 hours, it is possible that our assay at 24 hours misses 
the peak of circulating mtDNA (Remick et al., 2002). 
 
Figure 1. Plasma IL-6 Predicts Mortality 24 Hours Post CLP. (a) CLP was 
performed to induce ~50% mortality in ICR7 outbred mice. (b) Plasma was 
collected at 24 hours while animals were monitored for survival. ROC curve 
analysis was used to generate IL-6 values predictive of mortality for mice sacrificed 
at 24 hours for their total blood volume. N=8-10/group sampled at 24 hours, N 
represents an individual mouse. ***=p<0.0001 
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Prior in vitro studies have shown that mtDNA elicits inflammation in neutrophils and 
macrophages in states of shock (Zhang et al., 2010). We hypothesized that mtDNA 
would behave similarly to known sepsis-inducer LPS, and cause an increase in 
proinflammatory cytokine mRNA stability. To determine this, peritoneal macrophages 
were isolated and production of TNF-α and IL-6 was observed after exposure to LPS, 
mtDNA, and mitochondrial debris. Mouse liver was used as a source of purified mtDNA, 
which was assayed using cytB2, a mitochondrial specific primer, and HPRT, a nuclear 
specific primer, to assess for purity. Our preparation demonstrated minimal nuclear 
contamination in an assayed sample of purified mtDNA, as shown by early amplification 
Figure 2. Plasma mtDNA is Elevated 24 Hours Post CLP in Mice Predicted to 
Die. Data from 5 independent experiments, N=10 mice/group at 24 hours. 
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of cytB2 in the sample, and little HPRT amplification even at amplification cycles 30-23 
(Figure 3). 
 
 
 
Figure 3. Purified mtDNA from Mouse Liver was Minimally Contaminated. Purified 
mtDNA was assayed by qPCR with a mitochondria specific primer, cytB2, and a nuclear 
specific primer, HPRT. The early amplification of cytB2 between cycles 6 and 16 versus 
the later amplification of HPRT at 30 to 32 cycles demonstrates minimal HPRT presence 
in the liver samples as compared to cytB2. 
 
This purified mtDNA was added at a concentration of 100 ug/mL, which was determined 
by our laboratory and others to be more effective than stimulation using concentrations of 
1 or 10 ug/mL, respectively (data not shown; Zhang et al., 2010). Sonicated whole 
mitochondria was also used as a stimulus at a dilution of 1% of mitochondrial debris 
obtained from a single mouse liver per 4.4 mL of media.  This amount of debris was 
demonstrated to be effective at stimulating a 24-well sample of macrophages through a 
titration experiment (Figure 4). While our data did not prove significant from this single 
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experiment, it provides directional evidence of increased TNF-α expression that is 
congruent with similar stimulation experiments by other groups. 
 
 
Figure 4. Titration of Mitochondrial Debris. A titration of mitochondrial debris was 
used to determine the most effective dilution to stimulate macrophages. Per 3.5x105 
macrophages, the dilution of mitochondrial debris that elicited the greatest change in 
TNF-α cytokine production was 1%. 
 
Known pro-inflammatory stimulus LPS was also followed as a positive control. The total 
RNA of cells collected at 4 hours following stimulation was assayed for TNF-α mRNA 
levels using qRT-PCR (Figure 5). Differences in cytokine expression measured by qRT-
PCR between experiments are attributed to variability between individual experimental 
animals. The differential expression between LPS and other inflammatory mediators in 
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this particular experiment was not found to be significant, suggesting that these mediators 
may have as great of an effect as LPS stimulation on cytokine mRNA expression. 
 
 
 
 
 
 
 
 
The cell culture media of the stimulated macrophages was assayed for secreted TNF-α  
using ELISA, demonstrating a similar increase in cytokine expression released into the 
cell’s surroundings following administration of LPS, mtDNA or mitochondrial debris, 
which was significantly higher on comparison with stimulation by cell culture media 
alone (Figure 6). TNF-α secretion into the media was also significantly higher after 
stimulation with mitochondrial DNA than with LPS. 
Figure 5. TNF-α mRNA is Induced by mtDNA and Mitochondrial Debris as it 
is by LPS. Primary macrophages stimulated with mtDNA and mitochondrial debris 
were assayed for their TNF-α mRNA content using qPCR. 
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Figure 6. TNF-α Cytokines are Found in Cell Media After Induction by mtDNA and 
Mitochondrial Debris. The culture media of primary macrophages was assayed using 
ELISA for TNF-α, demonstrating that mtDNA and mitochondrial debris increases the 
production of TNF-α secreted into the surroundings. *=p<0.05, ***=p<0.0001 
 
 
Expression of pro-inflammatory cytokine IL-1β by mtDNA and mitochondrial debris-
stimulated macrophages was also assayed via qPCR. Findings demonstrated an increase 
in IL-1β mRNA production in cells treated with mitochondrial products (Figure 7). 
However, little response from debris-treated cells suggests this cytokine’s production 
may demonstrate a different expression peak than at the chosen time of our assay. This 
suggests that mtDNA effects the production of other pro-inflammatory cytokines besides 
TNF-α in its alteration of the septic immune response, although time course may vary. 
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Figure 7. IL-1β mRNA is also Induced by Stimulation with mtDNA and 
Mitochondrial Debris. Primary macrophages stimulated with mtDNA and mitochondrial 
debris were also assayed for their IL-1β mRNA content using qPCR, demonstrating an 
increase in mRNA expression compared to that of macrophages stimulated with media 
alone. 
 
Having identified that TNF-α mRNA production was effectively induced by mtDNA and 
mitochondrial debris, its half-life was determined using qRT-PCR to determine the 
effects of these inflammatory mediators on transcript stability. Macrophages were 
stimulated for two hours with LPS, mtDNA and mitochondrial debris before the addition 
of actinomycin D, an inhibitor of transcription. Samples were harvested at various time 
points, and RNA was extracted from lysed cells to assay for mRNA expression over time. 
Control cells did not have detectable levels of TNF-α, and thus the half-life of its 
extracted RNA was not calculated. The average half-life for the cytokine as elicited by 
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each inflammatory stimuli is included in table 1. This experiment demonstrated increased 
TNF-α half-life in cultures stimulated by LPS, mtDNA, and mitochondrial debris, as 
compared to stimulation with culture media alone (Figure 8, data representative of 
several experiments). Differences in half-life between inflammatory mediators were not 
significant, suggesting that they regulate TNF-α mRNA half-life to the same extent as 
LPS. 
 
 
Figure 8. TNF-α mRNA Stability is Increased by Stimulation with LPS, mtDNA or 
Mitochondrial Debris. qRT-PCR of TNF-α produced by macrophages stimulated with 
LPS, mtDNA, and debris for two hours before inhibition of all transcription with 
actinomycin D (Act. D) demonstrates an increase in TNF-α half-life by all three stimuli. 
The figure shown is a representative experiment, three separate time point assays were 
included in half life calculations. 
 
LPS mtDNA Mitochondrial Debris 
42.56 ± 15.52 minutes 55.28 ± 21.22 minutes 
 
71.56 ± 46.91 minutes 
 
Table 1. TNF-α mRNA Half Life is Increased by Stimulation With Inflammatory 
Stimuli. qRT-PCR relative quantification of TNF-α mRNA allowed for assaying of the 
cytokine’s half life. Average TNF-α mRNA half life was demonstrated to increase upon 
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stimulation with inflammatory mediators LPS, mtDNA, and mitochondrial debris. This 
data represents the average cytokine half-life for three experiments. 
 
 
We next examined the RNA binding protein, AUF1, which as previously been shown to 
regulate TNF-α in response to LPS treatment (Lu et al., 2006). To observe the activity of 
the RNA binding proteins involved in stabilizing TNF-α mRNAs, macrophage cell 
lysates subjected to immunoprecipitation with AUF1 antibodies, and then assayed with 
RT-PCR to determine the relative binding of TNF-α transcripts to the AUF1 protein. This 
experiment employed mitochondrial debris as the standard stimulation rather than 
mtDNA, as this scenario is what is more likely occurring in plasma from septic patients. 
This experiment demonstrated increased TNF-α mRNA binding to AUF1 by samples 
stimulated with mitochondrial debris than the control and even LPS-stimulated 
immunoprecipitation (IP) samples (Figure 9). 
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Figure 9. AUF1-Immunoprecipitated RNA-Protein Complexes Express High TNF-α 
in LPS and Mitochondrial Debris-Stimulated Samples. qRT-PCR of macrophage 
pellets immunoprecipitated (IP) with AUF1 antibodies demonstrated that macrophages 
stimulated with LPS and mitochondrial debris express higher TNF-α than control samples. 
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DISCUSSION 
 
 
Sepsis is a costly health concern that is a life-threatening condition that can leave 
survivors with functional deficits, a diminished quality of life, and increased long-term 
mortality (Perl et al., 1995). In the acute stage of inflammation and sepsis, pro-
inflammatory mediators produced by leukocytes enhance the development of exaggerated 
cytokine production, where elevated pro-inflammatory cytokine levels correlate with 
increased mortality. These pro-inflammatory cytokines include TNF-α, IL-6, and IL-1β, 
targets whose suppression has not yet lead to development of an effective therapeutic 
agent against inflammatory disease (Newham et al., 2014; Remick, 2003).  
It is known that the production of these inflammatory cytokines is regulated at multiple 
levels, including gene transcription and mRNA translation, degradation, and stability 
(Stumpo et al., 2010).  
 
The evolutionary endosymbionts that power eukaryotic cells, mitochondria, have been 
shown to act as endogenous damage-associated molecular patterns (DAMPs) when 
released into the circulation during injury. They therefore function as important mediators 
in innate immunity activation. Previous studies have demonstrated this through 
measuring plasma mtDNA levels in ICU patients, where elevated levels at 24 hours post-
injury correlate with increased cytokine production and sepsis severity (Zhang et al., 
2010). We have examined this role of mtDNA in vivo using a CLP sepsis model, and 
demonstrated that plasma mtDNA levels are also elevated in CLP mice predicted to die 
when stratified using an IL-6 Receiver Operator Characteristic curve. Our study also took 
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into consideration the administration of post-procedure antibiotics at similar intervals and 
regimens provided to human patients, an aspect of current clinical care usually excluded 
from traditional CLP studies. This shows that clinically relevant models employing 
current interventions still demonstrate high mortality and increased plasma mtDNA in 
response to septic insult. However, it is still unknown whether these mtDNA level 
increases are simply due to correlation with injury severity, or if the mtDNA itself has a 
causative role in septic progression. We sought to determine if elevated plasma mtDNA 
activates cytokine production and therefore contributes to sepsis mortality through in 
vitro examination of the cytokine mRNA induction in cells of the innate immune system, 
notably primary macrophages.  
Assays of cytokine mRNA elicited from primary macrophages stimulated with mtDNA 
demonstrated increased TNF-α expression, as expected from a review of previous studies 
(Zhang et al., 2010; Cao et al., 2014).  However, stimulation using mitochondrial debris 
also elicited a strong induction of TNF-α when assayed using qPCR and ELISA. This 
demonstrates that both mtDNA and mitochondrial debris can induce TNF-α mRNA 
production in macrophages, similar to published data on LPS induction of TNF-α (Park, 
2013). In this situation, LPS binding to binding to toll-like receptor (TLR) 4 activates the 
innate immune response to upregulate cytokine production (Beutler et al., 2003). TLRs 
are pattern-recognition receptors that recognize the products of a given pathogen or 
danger-associated molecular pattern (DAMP), and Mitochondrial DAMPs can activate 
TLR9 signaling similar to TLR4 activation observed with LPS stimulation (Carchman et 
al., 2013). TLR9 is localized to endocytic compartments and homodimerizes to recognize 
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unmethylated cytosine-phosphodiester-guanine (CpG)-containing DNA motifs present in 
viral and bacterial DNA, as well as the mitochondrial genome. Animal models with 
mutations in the TLR9 receptor have also demonstrated decreased mortality after 
experimental sepsis (Plitas et al., 2008). Thus, mitochondrial DAMPs may activate 
several TLR and likely have a synergistic effect in inducing pro-inflammatory cytokine 
production. These findings further compound the role mtDNA may play in activating 
host innate immunity and initiating the cytokine production that can lead to severe sepsis 
and increased mortality.  
IL-1β expression as influenced by mtDNA and mitochondrial debris stimulation was also 
examined, as this pro-inflammatory cytokine is one of the most important product a 
macrophage can produce to modulate inflammation (Lu et al., 2013). IL-1β induction has 
been involved in several acute and chronic inflammatory diseases, such as inflammatory 
bowel disease, rheumatoid arthritis, and sepsis, meriting its inclusion in this study 
(Kuiper et al., 1998; Dinarello et al., 1993). As predicted by the literature, increased IL-
1β production was observed in macrophages treated with titrations of mtDNA and 
mitochondrial debris. This demonstrates the effectiveness of increased plasma mtDNA in 
eliciting a septic response with high mortality, as immune cell stimulation by mtDNA 
induces the production of multiple inflammatory cytokines. 
 
To further illuminate the role of these inflammatory mediators on mRNA expression, we 
next examined the kinetics of mtDNA and mitochondrial debris stimulation on cytokine 
production. Regulated mRNA stability and mitochondrial dysfunction are two largely 
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unexplored aspects of sepsis biology, though it is known that mtDNA activates TLR 
signaling, which initiates a cascade linked to the regulation of mRNA stability. As many 
of these cytokines are short-lived due to their unstable mRNAs, cytokine mRNA stability 
can be increased via interaction with various RNA-binding proteins. The outcome of the 
septic inflammatory response is dependent on the regulation of pro- and anti-
inflammatory cytokines and these associated proteins (Stumpo et al., 2010). We aimed to 
demonstrate if the interaction of mtDNA or mitochondrial debris on pro-inflammatory 
cytokine action involved alterations in mRNA stability through such RNA-protein 
interactions. Primary macrophages treated with mtDNA and mitochondrial debris were 
assayed over an 18 hour period post-stimulation, and qPCR analysis of stimulated 
samples demonstrated an increase in TNF-α mRNA half-life. These findings suggest that 
circulating mitochondrial DNA and debris both impact cytokine production through 
altering mRNA stability, potentially through interaction and regulation of an RNA-
binding protein. This is substantiated by the fact that many inflammatory cytokines have 
AU-rich elements (ARE) in their 3’-untranslated regions (UTRs), and RNA-binding 
proteins such as AUF1 can bind these ARE and regulate the stability and translation of 
the mRNA (Stumpo et al., 2010; Sarkar et al., 2003). These findings suggest that mtDNA 
and mitochondrial debris act to regulate cytokine mRNA stability through the activity of 
RNA-binding proteins. 
 
Several ARE-binding proteins have been identified, including three that are involved in 
the regulation of rapid mRNA decay in vivo (Brewer and Ross, 1989; Sarkar et al., 2003). 
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One of these regulating proteins is the ARE- and poly(U)-binding and degradation factor, 
AUF1, which we chose to examine in our study of the involvement of mtDNA in 
cytokine mRNA stability (Ma et al., 1996). This protein demonstrates mRNA-
destabilizing activity in vivo for several short-lived transcripts of interest (DeMaria et al., 
1996; Laroia and Schneider, 2002). Unstable mRNAs, including those of inflammatory 
cytokines, are often regulated by ARE sequences that can be bound by ARE-degradation 
factors like AUF1. Given this evidence, we sought to determine the interaction of 
mitochondrial debris-stimulated cytokine mRNA with AUF1 through 
immunoprecipitation. Our study resulted in increased TNF-α mRNA immunoprecipitated 
with AUF1 antibodies from whole cell lysates that had been stimulated by mitochondrial 
debris as compared to culture media, or receiving LPS stimulation. This finding 
reinforces the potential regulation of inflammatory cytokine mRNA through 
mitochondrial DAMP-mediated AUF1 interaction. As such, it suggests also that 
mitochondrial debris and mtDNA regulate sepsis progression through the destabilizing 
factors of pro-inflammatory cytokine mRNA.  
This finding relates to work done by Blackshear and colleagues on the regulation of IL-6, 
IL-10, and TNF-α mRNA by the MAPK phosphatase, MKP-1 (Yu et al., 2011). MKPs 
are dual-specificity protein phosphatases which dephosphorylate the tyrosine and 
threonine residues of activated MAPK pathways. These pathways are involved in 
immune response signaling in response to stress stimuli and infectious microorganisms, 
allowing MKPs to attenuate exaggerated inflammation. This was demonstrated in a 
MKP-1 knockout model, which was highly susceptible to endotoxic shock and displayed 
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increased production of TNF-α, IL-6, and IL-10 (Chi et al., 2006). The role of MKP-1 in 
the degradation of the mRNAs of these cytokines after LPS stimulation was observed by 
Yu et al. (2011), who demonstrated that MKP-1 knockout mice exhibited a 2-fold slower 
degradation of TNF-α mRNA, where the half-life was 0.6 hours. They also demonstrated 
this activity with an in vitro model of rat macrophages, where macrophages transduced 
with a gene for MKP-1 had a 1.8-fold decrease in TNF-α mRNA half-life (t1/2 = 1.5 hours 
with MKP-1). This finding validates our demonstrated TNF-α half-life following 
stimulation by LPS, mtDNA and mitochondrial debris, and suggests that mitochondrial 
products act similarly to LPS in their activation of the immune response. Previous studies 
have also demonstrated that the mRNA destabilizing AUF1 could be phosphorylated at 
multiple serine and threonine sites or form a complex with other proteins, suggesting that 
the threonine-dephosphorylating activity of MKP-1 could be either directly or indirectly 
related to AUF1-targeted mRNA stability (Wilson et al., 2003). Yu and colleagues 
(2011) demonstrated that MKP-1 expression is correlated with AUF1 intracellular 
translocation, demonstrating increased cytoplasmic accumulation of the protein. 
Increased cytoplasmic AUF1 was found to be associated with ARE-dependent mRNAs, 
and the decreased half-life of these targeted cytokines. These findings demonstrate a 
strong role for AUF1 in the innate immune response through attenuation of cytokine 
mRNA expression. 
 
To understand the function of AUF1 in the systemic inflammatory response, previous 
studies have developed an AUF1 knockout mouse that displays symptoms of severe 
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endotoxic shock upon endotoxin challenge (Lu et al., 2006). This endotoxemia induced 
high mortality from overproduction of TNF-α and IL-1β, two cytokines whose 
overexpression specifically results from an inability to rapidly degrade these mRNAs in 
macrophages following induction. We anticipate that if macrophages extracted from 
wild-type and AUF1 knockout mice were assayed for cytokine mRNA stability as we 
have outlined above, results would demonstrate an increase in pro-inflammatory cytokine 
production in macrophages obtained from the knockout model. This in vitro extension of 
our current model would determine the contribution of AUF1 to the upregulation of 
cytokine mRNA and severity of septic shock in response to increased circulating mtDNA 
and mitochondrial debris. 
 
Future in vivo studies of effective therapies targeting mitochondrial DAMPs in septic 
shock would involve analysis of the mitochondrial fission inhibitor, mdivi-1. 
Mitochondrial fusion and division is affected by proteins that regulate mitochondrial 
membrane dynamics, and are critical in the cellular functioning of this organelle and the 
cell as a whole. Mitochondrial fusion itself can attenuate apoptosis through inhibition of 
the release of cytochrome c from mitochondria, partially through the control of cristae 
structures (Neuspiel et al., 2005). As mitochondrial division promotes apoptosis, the 
various proteins involved in division could prove to be potential therapeutic targets. 
Mitochondrial fusion can be inhibited by the compound mdivi-1, which was 
demonstrated to be a general suppressor of mitochondrial fusion defects by inhibiting 
mitochondrial division (Cassidy-Stone et al., 2008). Studies have demonstrated that 
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mdivi-1 prevents apoptosis by inhibiting mitochondrial outer membrane permeabilization, 
and blocks Bid-activated Bax/Bak-dependent cytochrome c release from mitochondria in 
vitro. Alone, this finding has the potential to affect many disease states, including stroke, 
myocardial infarction, and various neurodegenerative diseases where cellular apoptosis 
drives disease progression (Chen et al., 2005). Prevention of mitochondrial division 
would protect against mass tissue cell apoptosis, and benefit the prognosis of these 
diseases and, of course, sepsis.  
Indeed, a study by Gonzalez et al. (2014) using a CLP model evaluated mitochondrial 
biogenesis and mdivi-1 administration on sepsis outcome. Their observations 
demonstrated that the balance between mitochondrial fission and fusion determines 
differential survival rates between mice subjected to CLP. Their study also demonstrated 
that the lower mortality associated with LPS-induced sepsis was related to differential 
expression of inducible nitric oxide synthase, a component of innate immunity and an 
antimicrobial agent. Oxidative stress occurring due to sepsis can increase mitochondrial 
biogenesis, increased mtDNA content, or mitochondrial fragmentation. This balance of 
fission and fusion of mitochondria modulates the shape, size, and number of 
mitochondria to alter their physiological function (Suen et al., 2008). Gonzalez and 
colleague’s usage of the mitochondrial division inhibitor mdivi-1 with a CLP model 
prevented the inhibition of mitochondrial electron transport chain complexes and 
hepatocyte apoptosis (Gonzalez et al., 2014). As loss of mitochondrial fusion appears to 
be correlated with progressive mitochondrial damage, it was natural that blocking 
mitochondrial fission through the inhibition of Drp1 self-assembly attenuated CLP 
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mitochondrial apoptosis. This finding suggests that targeting Drp1 could potentiate a 
therapeutic tool for sepsis. However, this study also administered mdivi-1 pre-CLP, 
whereas future clinical treatments would likely only occur after clinical presentation of 
sepsis. It is therefore of interest to administer mdivi-1 to CLP animals post-procedure to 
best assess its clinical utility. 
 
It has also been demonstrated that one of the fundamental roles of mitochondrial fusion is 
to allow for exchange of mtDNA and its products, permitting increased mitochondrial 
“connectivity” (Hoppins et al., 2007). Inhibition of this mechanism could benefit 
heteroplasmic mtDNA-linked diseases, such as sepsis, where more than one 
mitochondrial genome is present within an affected individual. This finding could 
therefore provide a potent target for therapeutics that would address the increased plasma 
mtDNA levels we have demonstrated to be present in the plasma of CLP mice with 
increased mortality. From this examination of mtDNA levels in CLP animals and 
previous studies of mtDNA in the plasma of septic ICU patients, it is imaginable that 
severely septic patients could be stratified by their circulating mtDNA levels—as we 
have stratified our mice using their serum IL-6—allowing for appropriately titrated 
treatment with mdivi-1 and blockage of further inflammatory signaling (Nakahira et al., 
2013). Should our mdivi-1 treated CLP model prove effective, the availability of multiple 
target points in the promotion of mitochondria fusion offers many avenues for future 
exploration into molecular treatments for sepsis. As also demonstrated by various studies, 
it has been suggested that this manner of treatment could provide successful treatment for 
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a variety of inflammatory and mitophagy-involved conditions (Sadri and Schneider, 
2009; Mizumura et al., 2014).  
Previous findings on sepsis treatments demonstrate targeting cytokine action alone has 
failed, and suggest targeting a different mechanism of the inflammatory pathway to 
abrogate the intense cytokine production characteristic of severe sepsis (Kox et al., 2000). 
Thus, examination of the cytokine profiles of AUF1 knockout and wild-type mice 
subjected to CLP and treatment with mdivi-1 could offer a potential therapy for sepsis 
treatment. 
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